Home/ Supplements/ Melatonin/ Melatonin Chewable 1 mg

Melatonin Chewable 1 mg

product on market Tablet or Pill Kirkman Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Melatonin is a hormone that helps regulate sleep-wake cycles and is supported by strong evidence for reducing sleep onset latency. Research indicates it is effective for managing short-term insomnia and jet lag. The ingredient profile is generally considered safe for short-term use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Melatonin Chewable 1 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
100
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Sorbitol Mannitol Sodium Starch Glyconate Magnesium Stearate natural Mint Flavor
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested use: Take one tablet one hour before bed time or as directed by a physician. Tablet may be chewed or dissolved under the tongue.

Warnings & Precautions

Keep out of the reach of children.

Do not drive motor vehicle or operate machinery after taking this product.

Formulation Notes

Free of: milk, eggs, fish, shellfish, tree nuts, peanuts, wheat or soy

Gluten-free

Additional Information

Important: Store in a cool dry place and tightly capped.

Ultra Tested cGMP Certified Current Good Manufacturing Practice Consistent Quality

Metadata

Product Details

UPC / SKU8 12325 02045 4
DSLD Entry Date2025-05-21
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
BrandKirkman
DSLD ID333051
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.